Generic drugs don't appear immediately after patent expiration. Legal hurdles, patent thickets, and regulatory delays often push market launch out by 18 months or more - costing patients billions. Here's how the system really works.
View More
Tentative FDA approval for generic drugs doesn't mean they're ready to sell. Patent fights, manufacturing flaws, and incomplete applications cause major delays - keeping prices high and patients waiting.
View More